ES2053907T3 - Pomada topica. - Google Patents
Pomada topica.Info
- Publication number
- ES2053907T3 ES2053907T3 ES89119890T ES89119890T ES2053907T3 ES 2053907 T3 ES2053907 T3 ES 2053907T3 ES 89119890 T ES89119890 T ES 89119890T ES 89119890 T ES89119890 T ES 89119890T ES 2053907 T3 ES2053907 T3 ES 2053907T3
- Authority
- ES
- Spain
- Prior art keywords
- pct
- topical
- pomada
- sec
- date
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
UNA POMADA QUE SE UTILIZA PARA EL TRATAMIENTO LOCAL DE DERMATOSIS (PSORIASIS), CONTIENE: DE 10 A UN 50% EN PESO DE VASELINA; UN 10 A 50% EN PESO DE YUYUBA; UNO A 10% EN PESO DE CERA DE ABEJAS O ESPERMA DE BALLENA Y UN 10 A 40% EN PESO DE AGUA. EL RESULTADO DE LA APLICACION DE LA POMADA CON ESTA COMPOSICION SE ENCUENTRA EN LA VANGUARDIA DE LA ACCION FARMACEUTICA DE COLESTERINA. LA POMADA SE CARACTERIZA POR LA BUENA TOLERABILIDAD POR PARTE DEL PACIENTE A DICHA POMADA Y LA NO PRESENCIA DE REACCIONES ALERGICAS DE LA PIEL SOMETIDA AL UNGUENTO DE LA POMADA
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3836971A DE3836971C1 (es) | 1988-10-31 | 1988-10-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2053907T3 true ES2053907T3 (es) | 1994-08-01 |
Family
ID=6366210
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES89119890T Expired - Lifetime ES2053907T3 (es) | 1988-10-31 | 1989-10-26 | Pomada topica. |
Country Status (11)
Country | Link |
---|---|
US (1) | US5179086A (es) |
EP (2) | EP0367103B1 (es) |
JP (1) | JPH0647544B2 (es) |
AT (1) | ATE84216T1 (es) |
CA (1) | CA2001797A1 (es) |
DE (2) | DE3836971C1 (es) |
DK (1) | DK7191A (es) |
ES (1) | ES2053907T3 (es) |
GR (1) | GR3007370T3 (es) |
PT (1) | PT92148B (es) |
WO (1) | WO1990004967A2 (es) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2705030A1 (fr) * | 1993-05-11 | 1994-11-18 | Biodev | Utilisation de composés stéroliques pour la fabrication d'un médicament anti-inflammatoire. |
US5888984A (en) | 1994-05-12 | 1999-03-30 | Dermal Research Laboratories, Inc. | Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same |
US5444092A (en) * | 1994-07-20 | 1995-08-22 | Collins; Jerry | Method and composition for treating psoriasis |
GB9814527D0 (en) * | 1998-07-03 | 1998-09-02 | Cyclacel Ltd | Delivery system |
ATE419273T1 (de) | 1998-11-13 | 2009-01-15 | Cyclacel Ltd | Translokationsvektoren abgeleitet von der antennapedia homeodomain helix 3 |
WO2000044367A2 (en) | 1999-02-01 | 2000-08-03 | Dermal Research Laboratories, Inc. | A pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same |
US7879824B2 (en) | 2001-07-31 | 2011-02-01 | Dermal Research Laboratories, Inc. | Methods of preventing or treating diseases and conditions using complex carbohydrates |
TNSN02063A1 (en) * | 2001-07-07 | 2005-12-23 | Egyptian Natural Oil Co Natoil | The medical effect of jojoba oil |
US7048914B2 (en) * | 2002-12-12 | 2006-05-23 | Zoltan Laboratories | Placental alkaline phosphatase to control diabetes |
US20050002884A1 (en) * | 2003-07-02 | 2005-01-06 | Marsella Jefferson | Hair treatment compositions |
US7374754B2 (en) * | 2003-09-02 | 2008-05-20 | Essential Skincare, Llc | Use of placental alkaline phosphatase to promote skin cell proliferation |
US8455016B2 (en) * | 2004-03-12 | 2013-06-04 | Melbj Holdings, Llc | Treatment for meibomian gland dysfunction or obstruction |
US7695714B2 (en) * | 2005-12-28 | 2010-04-13 | Zoltan Laboratories Llc | Use of alkaline phosphatase to maintain healthy tissue mass in mammals |
EA201170286A1 (ru) * | 2008-12-24 | 2011-10-31 | Байомедкор Инк. | Способ получения липосом и способ растворения холестерина |
US20130053357A1 (en) | 2010-04-28 | 2013-02-28 | Hisamitsu Pharmaceutical Co., Inc. | Skin irritation suppressant and transdermal preparation |
WO2011136288A1 (ja) | 2010-04-28 | 2011-11-03 | 久光製薬株式会社 | ドネペジル含有経皮吸収製剤 |
ES2786504T3 (es) | 2011-10-26 | 2020-10-13 | Hisamitsu Pharmaceutical Co | Preparación de absorción transdérmica que contiene oxibutinina |
US9717741B2 (en) | 2012-10-11 | 2017-08-01 | Anaplasi Pharmaceuticals Llc | Method and compositions for treating psoriasis |
US9987361B1 (en) | 2014-12-29 | 2018-06-05 | Noven Pharmaceuticals, Inc. | Compositions and method for sustained drug delivery by active transdermal technology |
GB201814036D0 (en) | 2018-08-29 | 2018-10-10 | Ucl Business Plc | New therapy |
US20210393724A1 (en) * | 2018-11-01 | 2021-12-23 | Yeditepe Universitesi | Medicine for treatment of psoriasis and production method thereof |
GB201918752D0 (en) * | 2019-12-18 | 2020-01-29 | Ucl Business Plc | New therapy |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE523144C (de) * | 1927-09-11 | 1931-04-20 | Friedrich Passek | Verfahren zur Herstellung wasserreicher Cholesterinloesungen |
DE638839C (de) * | 1935-01-15 | 1936-11-24 | Chem Fab Promonta G M B H | Verfahren zur Herstellung waessrig-alkoholischer Cholesterinloesungen |
FR928337A (fr) * | 1946-05-20 | 1947-11-25 | Procédé d'obtention de solutions stables de cholestérine, en vue de la préparation de produits cosmétiques et de beauté | |
FR2485921A1 (fr) * | 1980-07-01 | 1982-01-08 | Oreal | Composition cosmetique a base d'une dispersion aqueuse de spherules lipidiques |
IT8221553A0 (it) * | 1982-05-28 | 1982-05-28 | Gruppo Scient Revici Pacelli | Composizioni farmaceutiche adattivita' antineoplastica. |
DE3225849A1 (de) | 1982-07-07 | 1984-01-19 | Schering Ag | Kortikoidhaltige zubereitung zur topischen applikation |
FR2568142B1 (es) * | 1984-07-26 | 1989-11-17 | Oreal | |
US4743597A (en) * | 1986-01-27 | 1988-05-10 | Javitt Norman B | Composition comprising an oxygenated cholesterol and use thereof for topical treatment of diseases |
FR2597346B1 (fr) * | 1986-04-22 | 1989-08-18 | Oreal | Procede pour faciliter la formation de niosomes en dispersion dans une phase aqueuse et pour ameliorer leur stabilite et leur taux d'encapsulation, et dispersions correspondantes. |
-
1988
- 1988-10-31 DE DE3836971A patent/DE3836971C1/de not_active Expired - Lifetime
-
1989
- 1989-10-26 JP JP1511363A patent/JPH0647544B2/ja not_active Expired - Lifetime
- 1989-10-26 US US07/671,740 patent/US5179086A/en not_active Expired - Fee Related
- 1989-10-26 EP EP89119890A patent/EP0367103B1/de not_active Expired - Lifetime
- 1989-10-26 WO PCT/EP1989/001276 patent/WO1990004967A2/de not_active Application Discontinuation
- 1989-10-26 AT AT89119890T patent/ATE84216T1/de not_active IP Right Cessation
- 1989-10-26 ES ES89119890T patent/ES2053907T3/es not_active Expired - Lifetime
- 1989-10-26 DE DE8989119890T patent/DE58903222D1/de not_active Expired - Fee Related
- 1989-10-26 EP EP89912240A patent/EP0440715A1/de active Pending
- 1989-10-30 PT PT92148A patent/PT92148B/pt not_active IP Right Cessation
- 1989-10-30 CA CA002001797A patent/CA2001797A1/en not_active Abandoned
-
1991
- 1991-01-15 DK DK007191A patent/DK7191A/da not_active Application Discontinuation
-
1993
- 1993-03-16 GR GR930400578T patent/GR3007370T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
JPH04501415A (ja) | 1992-03-12 |
DE3836971C1 (es) | 1990-05-17 |
DE58903222D1 (de) | 1993-02-18 |
WO1990004967A2 (de) | 1990-05-17 |
ATE84216T1 (de) | 1993-01-15 |
US5179086A (en) | 1993-01-12 |
EP0440715A1 (de) | 1991-08-14 |
GR3007370T3 (es) | 1993-07-30 |
JPH0647544B2 (ja) | 1994-06-22 |
CA2001797A1 (en) | 1990-04-30 |
PT92148A (pt) | 1990-05-31 |
WO1990004967A3 (de) | 1990-06-28 |
DK7191A (da) | 1991-06-04 |
EP0367103B1 (de) | 1993-01-07 |
DK7191D0 (da) | 1991-01-15 |
PT92148B (pt) | 1995-06-30 |
EP0367103A1 (de) | 1990-05-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2053907T3 (es) | Pomada topica. | |
PT912176E (pt) | Utilizacao de amidas do acido piridil-alcanoico piridil-alcenoico e/ou piridil-alcinico para o tratamento de tumores ou para imunossupressao | |
BG99261A (en) | Steroid glycosides for the treatment of hyperchlesterolemia | |
TR200200068T2 (tr) | Nematisital triflüorobütenler | |
BG46598A3 (en) | Method for preparation of alpha- heterocyclic substituted tolunitriles | |
DE59209810D1 (de) | Bestimmung von peptidmotiven auf mhc-molekülen | |
NO954320D0 (no) | Lyosfærer omfattende gonadotropin | |
DK0658348T3 (da) | Vandige opløsninger af inklusionskomplekser af benzothiophenforbindelser og cyclodextriner | |
BG102250A (en) | The use of marigold-extracted glycosides for the treatment of psoriasis | |
DK71387D0 (da) | Terapeutisk middel til behandling af psoriasis | |
ATE179594T1 (de) | Verwendung von ethisterone zur topischen behandlung von akne oder androgenetischer alopezie | |
ATE215084T1 (de) | Imidazopyridin-azolidinone | |
DK0841937T4 (da) | Anvendelse af betaglycan til reduktion af ardannelse | |
BR0007183A (pt) | Isonipectoamidas para o tratamento de distúrbios mediados por integrina | |
ATE222103T1 (de) | Inklusionskomplexe in waessriger loesung | |
ATE221068T1 (de) | Anellierte beta-carboline |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 367103 Country of ref document: ES |